The Business Research Company's Chronic Cough Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
Strong Future Growth Anticipated
The chronic cough market is projected to continue its strong growth, reaching $11.48 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to emerging therapies targeting specific pathways, increasing understanding of reflux-related cough, global efforts in smoking cessation, environmental and occupational health policies. Major trends in the forecast period include advancements in diagnostic technologies, patient-centric approaches, therapeutic innovations in neurogenic cough, telehealth for chronic cough management, research on central sensitization.
Explore Comprehensive Insights Into The Global Chronic Cough Market With A Detailed Sample Report:
https://www.thebusinessresearchcompany.com/sample_request?id=12109&type=smp
Growth Driver Of The Chronic Cough Market
The rise in the prevalence of cough is expected to propel the growth of the chronic cough market going forward. Cough refers to a reflex action that, frequently in response to irritation, mucus, or foreign objects, helps clear the airways by ejecting air forcefully from the lungs. A persistent cough that lasts for at least eight weeks is considered chronic. Therefore, when the incidence of cough rises, so do the cases of chronic cough.
Explore The Report Store To Make A Direct Purchase Of The Report:
https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report
Major Players And Market Trends
Key players in the chronic cough market include Tris Pharma Inc., Pfizer Inc., Johnson & Johnson Co, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Glaxo SmithKline PLC, Merck KGaA, Reckitt Benckiser Group PLC, Glenmark Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Mylan NV, Aurobindo Pharma Ltd., Cipla Limited, Apotex Inc., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Mount Sinai Health System, Biocon Ltd., BELLUS Health Inc., Trevi Therapeutics Inc., Sun Pharmaceutical Industries Ltd., NeRRe Therapeutics Ltd..
Major companies operating in the chronic cough market are concentrating on creating innovative products such as cough syrup to strengthen their position in the market. Cough syrup is used to treat upper respiratory allergies and common cold which contain non-opioid cough suppressants that acts on the cough center, a specific area of the brain, to assist stop coughing.
Segments:
1) By Drug Class: Antihistamines, Corticosteroids, Decongestants, Combination Drug, Antibiotics, Acid Blockers, Other Drug Classes
2) By Route Of Administration: Oral, Inhalational, Injectable, Other Route of Administrations
3) By End-Users: Hospitals, Homecare, Specialty Centers, Other End Users
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
Geographical Insights: North America Leading The Market
North America was the largest region in the chronic cough market in 2023. Asia-Pacific is expected to be the fastest-growing region during the forecast period, driven by expanding healthcare facilities and increasing awareness of the benefits of chronic cough.
Chronic Cough Market Definition
Chronic cough refers to a cough that is persistent and lasts for a long time, usually eight weeks or more. It frequently manifests as signs of an underlying illness, such as asthma, allergies, or respiratory infections.
Chronic Cough Global Market Report 2024 from THE BUSINESS RESEARCH COMPANY covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The Chronic Cough Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on chronic cough market size, chronic cough market drivers and trends, chronic cough market major players, chronic cough competitors' revenues, chronic cough market positioning, and chronic cough market growth across geographies. The chronic cough market report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Natural Gas Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/natural-gas-global-market-report
Oil Downstream Activities Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/oil-downstream-activities-global-market-report
Medical And Diagnostic Laboratory Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/medical-and-diagnostic-laboratory-services-global-market-report
About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn
Manufacturing Industry Overview with Comprehensive Market Data